Abbott Laboratories vs Intuitive Surgical

Abbott Laboratories (ABT), health care, and Intuitive Surgical (ISRG), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Abbott Laboratories is worth $184.1B on the stock market and Intuitive Surgical $149.7B: Abbott Laboratories is valued at 23% more. Abbott Laboratories trades at 39.7 times earnings and Intuitive Surgical at 52.2; operating margins in their latest fiscal years were 18.2% and 29.3%. Over the past year Abbott Laboratories's share price has moved -17.3% and Intuitive Surgical's -19.9%.

Key facts

Abbott Laboratories market value
$184.1B
Intuitive Surgical market value
$149.7B
Abbott Laboratories P/E
39.7
Intuitive Surgical P/E
52.2
Abbott Laboratories revenue
$44.3BFY to 2025-12-31
Intuitive Surgical revenue
$10.1BFY to 2025-12-31
Superinvestors holding both
4

Market values as of .

Abbott Laboratories vs Intuitive Surgical: every measure side by side
Measure Abbott Laboratories Intuitive Surgical
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$184.1Bhigher$149.7Blower
Revenue$44.3Bhigher$10.1Blower
Earnings$6.5Bhigher$2.9Blower
Employees122,000higher17,021lower
Total assets$86.7Bhigher$20.5Blower
Valuation
P/E39.7lower52.2higher
P/S4.2lower14.9higher
P/B3.6lower9.4higher
Dividend yield2.35%higher0.00%lower
Profitability
Operating margin18.2%lower29.3%higher
Balance sheet
Net assets$52.1Bhigher$17.8Blower
Total liabilities$33.9Bhigher$2.5Blower
Total debt$12.9B—
Cash on hand$8.5Bhigher$3.4Blower
Price change
Today-1.09%higher-1.36%lower
1 year-17.3%higher-19.9%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Abbott Laboratories / Intuitive Surgical). Who owns ABT · Who owns ISRG

Further comparisons

Learn

Questions and answers

Which is bigger, Abbott Laboratories or Intuitive Surgical?

By market value, Abbott Laboratories is the larger: $184.1B against $149.7B for Intuitive Surgical. By revenue in its latest fiscal year, Abbott Laboratories is the larger: $44.3B against $10.1B for Intuitive Surgical.

Which has the higher P/E ratio?

Intuitive Surgical: 52.2, against 39.7 for Abbott Laboratories. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Intuitive Surgical: 29.3%, against 18.2% for Abbott Laboratories. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Abbott Laboratories: 2.35%, against 0.00% for Intuitive Surgical. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Abbott Laboratories and Intuitive Surgical?

In their latest 13F filings, Jensen team, Jeremy Grantham (co-founder), Mairs & Power team and Brandon Haley hold both.

Cite this page

Funkfolio, “Abbott Laboratories vs Intuitive Surgical”, data as of 17 November 2026. https://funkfolio.com/compare/abt-vs-isrg

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.